Legal & General Group’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Buy |
234,588
+10,956
| +5% | +$21.4K | ﹤0.01% | 2469 |
|
|
2025
Q1 | $394K | Sell |
223,632
-1,195
| -0.5% | -$2.1K | ﹤0.01% | 2472 |
|
|
2024
Q4 | $598K | Buy |
224,827
+78,184
| +53% | +$208K | ﹤0.01% | 2392 |
|
|
2024
Q3 | $336K | Buy |
146,643
+17,057
| +13% | +$39.1K | ﹤0.01% | 2581 |
|
|
2024
Q2 | $380K | Buy |
129,586
+118,181
| +1,036% | +$347K | ﹤0.01% | 2513 |
|
|
2024
Q1 | $41.6K | Sell |
11,405
-5,184
| -31% | -$18.9K | ﹤0.01% | 2804 |
|
|
2023
Q4 | $25.1K | Sell |
16,589
-72,681
| -81% | -$110K | ﹤0.01% | 2945 |
|
|
2023
Q3 | $120K | Sell |
89,270
-2,294
| -3% | -$3.07K | ﹤0.01% | 2809 |
|
|
2023
Q2 | $165K | Buy |
91,564
+45,975
| +101% | +$82.8K | ﹤0.01% | 2776 |
|
|
2023
Q1 | $75.7K | Buy |
45,589
+4,635
| +11% | +$7.69K | ﹤0.01% | 2817 |
|
|
2022
Q4 | $78.6K | Hold |
40,954
| – | – | ﹤0.01% | 2867 |
|
|
2022
Q3 | $92K | Buy |
40,954
+1,786
| +5% | +$4.01K | ﹤0.01% | 2846 |
|
|
2022
Q2 | $127K | Sell |
39,168
-4,474
| -10% | -$14.5K | ﹤0.01% | 2789 |
|
|
2022
Q1 | $230K | Sell |
43,642
-43
| -0.1% | -$227 | ﹤0.01% | 2622 |
|
|
2021
Q4 | $371K | Buy |
43,685
+7,067
| +19% | +$60K | ﹤0.01% | 2509 |
|
|
2021
Q3 | $365K | Buy |
36,618
+26,655
| +268% | +$266K | ﹤0.01% | 2508 |
|
|
2021
Q2 | $92K | Buy |
+9,963
| New | +$92K | ﹤0.01% | 2769 |
|